Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Greenberger

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 19, 2006
Synthesis and biological study of 4-aminopyrimidine-5-carboxaldehyde oximes as antiproliferative VEGFR-2 inhibitorsShenlin Huang, Ronghua Li, Peter J Connolly, et al.
Molecular Cancer Therapeutics|November 1, 2008
A RNA antagonist of hypoxia-inducible factor-1alpha, EZN-2968, inhibits tumor cell growthLee M Greenberger, Ivan D Horak, David Filpula, et al.
Analytical Biochemistry|February 11, 2004
Development and comparison of two nonradioactive kinase assays for I kappa B kinaseTammy M Sadler, Maria Achilleos, Shoba Ragunathan, et al.
Gene Therapy|December 24, 2010
Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfectionY Zhang, Z Qu, S Kim, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Syntheses and EGFR and HER-2 kinase inhibitory activities of 4-anilinoquinoline-3-carbonitriles: analogues of three important 4-anilinoquinazolines currently undergoing clinical evaluation as therapeutic antitumor agentsAllan Wissner, M Brawner Brawner Floyd, Sridhar K Rabindran, et al.
Molecular Cancer Therapeutics|March 1, 2006
Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of beta-tubulin (Asp26Glu) and less stable microtubulesMalathi Hari, Frank Loganzo, Tami Annable, et al.
Angiogenesis|April 1, 2011
Potent and sustained inhibition of HIF-1α and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effectsPuja Sapra, Patricia Kraft, Fabio Pastorino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2010
Tumor regression and curability of preclinical neuroblastoma models by PEGylated SN38 (EZN-2208), a novel topoisomerase I inhibitorFabio Pastorino, Monica Loi, Puja Sapra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and ratsL M Greenberger, T Annable, K I Collins, et al.
Molecular Cancer Therapeutics|October 14, 2003
MAC-321, a novel taxane with greater efficacy than paclitaxel and docetaxel in vitro and in vivoDeepak Sampath, Carolyn M Discafani, Frank Loganzo, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry Letters|September 19, 2006
Synthesis and biological study of 4-aminopyrimidine-5-carboxaldehyde oximes as antiproliferative VEGFR-2 inhibitorsShenlin Huang, Ronghua Li, Peter J Connolly, et al.
Molecular Cancer Therapeutics|November 1, 2008
A RNA antagonist of hypoxia-inducible factor-1alpha, EZN-2968, inhibits tumor cell growthLee M Greenberger, Ivan D Horak, David Filpula, et al.
Analytical Biochemistry|February 11, 2004
Development and comparison of two nonradioactive kinase assays for I kappa B kinaseTammy M Sadler, Maria Achilleos, Shoba Ragunathan, et al.
Gene Therapy|December 24, 2010
Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfectionY Zhang, Z Qu, S Kim, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Syntheses and EGFR and HER-2 kinase inhibitory activities of 4-anilinoquinoline-3-carbonitriles: analogues of three important 4-anilinoquinazolines currently undergoing clinical evaluation as therapeutic antitumor agentsAllan Wissner, M Brawner Brawner Floyd, Sridhar K Rabindran, et al.
Molecular Cancer Therapeutics|March 1, 2006
Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of beta-tubulin (Asp26Glu) and less stable microtubulesMalathi Hari, Frank Loganzo, Tami Annable, et al.
Angiogenesis|April 1, 2011
Potent and sustained inhibition of HIF-1α and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effectsPuja Sapra, Patricia Kraft, Fabio Pastorino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2010
Tumor regression and curability of preclinical neuroblastoma models by PEGylated SN38 (EZN-2208), a novel topoisomerase I inhibitorFabio Pastorino, Monica Loi, Puja Sapra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and ratsL M Greenberger, T Annable, K I Collins, et al.
Molecular Cancer Therapeutics|October 14, 2003
MAC-321, a novel taxane with greater efficacy than paclitaxel and docetaxel in vitro and in vivoDeepak Sampath, Carolyn M Discafani, Frank Loganzo, et al.
Pageof 10